6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of October 2021

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  x                                                                 Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXPLANATORY NOTE

This Form 6-K is incorporated by reference into the Company’s registration statement on Form F-3 (Registration No. 333-249770) and Form S-8 (Registration No. 333-255635), and the following exhibit is filed as part of this Form 6-K:

Exhibit List

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

EXHIBIT 99.1

Bioceres Crop Solutions Corp. holds its 2021Annual Shareholders’ Meeting

New York, New York / October 27, 2021 - Bioceres Crop Solutions Corp. (“Bioceres Crop Solutions,” the “Company,” “we,” “us” or “our”) (NASDAQ: BIOX) held its 2021 Annual Shareholders’ Meeting (the “Meeting”) at the Company’s legal counsel’s office in New York, NY and virtually. At the Meeting, the Company’s shareholders voted on three proposals as set forth below, each of which is described in detail in the proxy statement filed by the Company on October 7, 2021. Each of the three proposals were approved at the Meeting by a simple majority of the shareholders who voted at the Meeting (either in person or by proxy).